This is a double-blind, placebo-controlled clinical trial to assess whether treatment with
lamotrigine and bupropion is more effective than placebo to reduce definitive Meniere's
vertigo attacks (DMVA) and dizziness in patients with Meniere's disease. Thirty four
participants will be randomized to treatment or placebo groups. Each participant will take
part in the trial for 34 weeks, or approximately 9 months.